Donald J. Trump Robert F. Kennedy Jr Dr. Mehmet Oz Marty Makary MD, MPH Please make Anktiva (Bioshield) available to all Cancer Patients now. Many have already gone through standard treatment of care. Could this be available under right to try? It is only approved by the FDA for a few cancers.

Biological Multichotomies – The Path Towards Dr. Patrick Soon Shiong’s Quantum Onco-Therapeutics? On and Off - The Dichotomy of T-Cells When investigating the behavior of T-cells (and other cells critical to the human immune system), Dr. Soon Shiong discovered a dichotomy

Will be an exciting JPM week. Will be co chairing the Inaugural USA Saudi Biotech Alliance with senior decision makers flying in to an exciting all day event. ImmunityBio, Inc., Nantworks reveal, biotechs, and bankers. More to come.

The missing link: making capital markets more efficient for all through blockchain-enabled tokenization. NantX — more to come. accessnewswire.com/newsroom/en/ba…

Slowly but surely ..insights being gained into how the body is a finely tuned biological exquisite system and by understanding the balance we can better treat life threatening diseases..from cancer to auto immune disease to the science of aging. Reveal at the USA: Saudi Biotech

FDA Commissioner Makary just announced less red tape 4 gene therapy development. Encouraging news. Here's the yes, but: Dr. Makary, it's time to cut red tape w the drug Anktiva too & make it available for patients w cancer & long Covid. Dr. Soon-Shiong's Anktiva restores

A decade of work at Nant and ImmunityBio, Inc. to be unveiled at this historic summit of USA-Saudi Alliance we convened. Honored that very senior leadership are attending from both Saudi and USA to address healthcare resiliency and patient access. Addressing checkpoint failures soon

We've announced the Inaugural U.S.-Saudi Biotech Alliance Summit, which will bring together national leaders from the United States and the Kingdom of Saudi Arabia across government, healthcare delivery, biotechnology, advanced manufacturing, artificial intelligence, and finance.

There is so much data to disclose that over the next few days we will announce results with Anktiva plus checkpoints in lung cancer,results with CAR NK cell therapy including CD-19 NK in lymphoma, PDL1-NK in Glooblastoma and head and neck cancer. Multiple press releases.!

Amazing breakthrough in lung cancer treatment! 🚀 ImmunityBio, Inc. 's ANKTIVA® combined with checkpoint inhibitors restored immune competence in 77% of advanced NSCLC patients, boosting survival to 21+ months—surpassing chemo standards! Independent of PD-L1. Hope rises!

Oncologists face the challenge of patients who progress on Keytruda and Opdivo. Recurrences of cancer after checkpoint inhibitors were predictable since T cells become exhausted. Anktiva RESCUES CHECKPOINTS. Positive results in #lungcancer of Anktiva plus Checkpoint out today.

First chemo free rescue of checkpoint inhibitors. First immunotherapy to activate BOTH NK and T Cells. First evidence in 2 tumors that ANKTIVA works as immunotherapy 2.0 - in bladder cancer with BCG and in lung and solid tumors with Keytruda and Nivo . Next Car-NK cell therapy.

UPDATE- Jesus Is LORD! Great news from today’s post-radiation scan! Dr. Hu at Cedars-Sinai says Andrew has NO new tumor or regrowth. The cavity has filled with brain matter—no swelling. He noted this is NOT typical & stands with us for the FDA approval of ANKTIVA to add to

Lori and her husband Andrew got good news after his MRI today following Anktiva treatment for his brain tumor (glioblastoma) 🍾🎊

It's shame for Trump's administration that FDA is still denying cancer patients access to Bioshield.

$IBRX ANKTIVA Dr. Marty Makary Lori Mills

$IBRX Adam, this narrative is getting really old, brother. Your repeated digs at $IBRX and the Saudi approval come across as petty and attention-seeking — it’s honestly starting to feel a bit childish and laughable at this point. Get a grip. Belittling the Saudi FDA and their

Her Royal Highness Princess Dr. Haya Al Saud joined ImmunityBio’s Founder, Executive Chairman, and Global Chief Scientific and Medical Officer Dr. Patrick Soon-Shiong for a discussion on the future of human health and resilience. As a leader of the Hevolution Foundation,

$IBRX Bioshield! What an inspiring moment for global health & longevity! Huge praise to Saudi Arabia and the visionary Hevolution Foundation for boldly redefining progress — making healthspan the true measure of success. Shoutout to HRH Princess Dr. Haya Al Saud — her